Mirja Erika Gunn1, Susanna Mört1,2, Mikko Arola3, Mervi Taskinen4, Pekka Riikonen5, Merja Möttönen6, Päivi Maria Lähteenmäki1. 1. Department of Pediatrics, Turku University Hospital, Turku, Finland. 2. Turku University of Applied Sciences, Turku, Finland. 3. Department of Pediatrics, Tampere University Hospital, Tampere, Finland. 4. Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland. 5. Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland. 6. Department of Pediatrics, Oulu University Hospital, Oulu, Finland.
Abstract
BACKGROUND: Reports on the quality of life (QOL) of childhood brain tumor (BT) survivors have been inconsistent. As cognitive limitations may restrict their participation in questionnaire-based studies, our aim was to evaluate in depth the QOL with a mixed-method analysis. METHODS: The 5-year survivors of childhood BTs born in 1975-2000 and alive in 2010 were identified via the Finnish Cancer Registry and treating clinics. Twenty-one survivors (32%) participated in a mixed-method analysis including 15D (a general health-related QOL questionnaire), the Beck Depression Inventory, and a qualitative semi-structured interview. RESULTS: Based on the 15D-questionnaire, the BT survivors had an impaired health-related QOL in several dimensions such as speech and usual activities. On the other hand, no difference was found in other dimensions such as distress or vitality. A majority (95%) of the survivors showed no increased risk for depression. The qualitative interview revealed that the most important aspects affecting the QOL of the survivors were positive mental growth, negative conceptions concerning illness, living one day at a time, age at diagnosis, time since diagnosis, social relationships, learning disabilities and limitations in vocational opportunities, limitations in independent life, and changed understanding of the term 'health'. CONCLUSIONS: Childhood BT survivors have heterogeneous attitudes on QOL. The survivors assess social aspects to be more important than functionality for their QOL. Social concerns should actively be brought up to offer support for those with significant social difficulties. Interventions for social difficulties should be more actively developed.
BACKGROUND: Reports on the quality of life (QOL) of childhood brain tumor (BT) survivors have been inconsistent. As cognitive limitations may restrict their participation in questionnaire-based studies, our aim was to evaluate in depth the QOL with a mixed-method analysis. METHODS: The 5-year survivors of childhood BTs born in 1975-2000 and alive in 2010 were identified via the Finnish Cancer Registry and treating clinics. Twenty-one survivors (32%) participated in a mixed-method analysis including 15D (a general health-related QOL questionnaire), the Beck Depression Inventory, and a qualitative semi-structured interview. RESULTS: Based on the 15D-questionnaire, the BT survivors had an impaired health-related QOL in several dimensions such as speech and usual activities. On the other hand, no difference was found in other dimensions such as distress or vitality. A majority (95%) of the survivors showed no increased risk for depression. The qualitative interview revealed that the most important aspects affecting the QOL of the survivors were positive mental growth, negative conceptions concerning illness, living one day at a time, age at diagnosis, time since diagnosis, social relationships, learning disabilities and limitations in vocational opportunities, limitations in independent life, and changed understanding of the term 'health'. CONCLUSIONS: Childhood BT survivors have heterogeneous attitudes on QOL. The survivors assess social aspects to be more important than functionality for their QOL. Social concerns should actively be brought up to offer support for those with significant social difficulties. Interventions for social difficulties should be more actively developed.
Authors: Elina Kyösti; Tero I Ala-Kokko; Pasi Ohtonen; Outi Peltoniemi; Paula Rautiainen; Janne Kataja; Hanna Ebeling; Janne H Liisanantti Journal: Intensive Care Med Date: 2018-08-22 Impact factor: 17.440
Authors: Maru Barrera; Eshetu G Atenafu; Fiona Schulte; Ute Bartels; Lillian Sung; Laura Janzen; Joanna Chung; Danielle Cataudella; Kelly Hancock; Amani Saleh; Douglas Strother; Dina McConnell; Andrea Downie; Juliette Hukin; Shayna Zelcer Journal: Support Care Cancer Date: 2017-04-14 Impact factor: 3.603
Authors: Carolyn R Bates; Diane Fairclough; Robert B Noll; Maru E Barrera; Mary Jo Kupst; Anna M Egan; Maria A Gartstein; Emily L Ach; Cynthia A Gerhardt; Kathryn Vannatta Journal: Pediatr Blood Cancer Date: 2022-01-19 Impact factor: 3.167
Authors: Ade Oyefiade; Iris Paltin; Cinzia R De Luca; Kristina K Hardy; David R Grosshans; Murali Chintagumpala; Donald J Mabbott; Lisa S Kahalley Journal: J Clin Oncol Date: 2021-04-22 Impact factor: 50.717
Authors: Brooke E Kohler; Emmah Baque; Carolina X Sandler; Denise S K Brookes; Caroline O Terranova; Matthew Rixon; Tim Hassall; Stewart G Trost Journal: BMC Pediatr Date: 2021-03-01 Impact factor: 2.125
Authors: Emma J Verwaaijen; Coriene E Catsman-Berrevoets; Heleen Maurice-Stam; Arianne B Dessens; Richelle Waslander; Tabitha P L van den Adel; Saskia M F Pluijm; Roel E Reddingius; Erna Michiels; Marry M van den Heuvel-Eibrink; Annelies Hartman Journal: Neurooncol Adv Date: 2021-11-03
Authors: Emma Nicklin; Lucy Pointon; Adam Glaser; Naseem Sarwar; Michelle Kwok-Williams; Miguel Debono; Galina Velikova; Florien W Boele Journal: Support Care Cancer Date: 2021-04-16 Impact factor: 3.603